Una organización internacional sin ánimo de lucro para fomentar el acceso y el uso adecuado de medicamentos entre la población hispano-parlante
Trazodona asociado con riesgo de caídas y fracturas, pero otros antipsicóticos atípicos tienen riesgos similares Jack Cush MD, MedPage Today, 1 de diciembre de 2018 https://www.medpagetoday.com/rheumatology/generalrheumatology/76616 Traducido por Salud y Fármacos La Canadian Medical Association Journal ha comunicado que el uso de trazodona entre ancianos podría estar asociado con el riesgo de caídas y fracturas […]
Mylan retira lotes de medicamentos para la presión arterial en EE UU (Mylan recalls batches of blood pressure medicine in U.S.) Reuters, 20 de noviembre de 2018 https://www.reuters.com/article/mylan-valsartan-united-states/mylan-recalls-batches-of-blood-pressure-medicine-in-u-s-idUSL4N1XV5GN El fabricante de medicamentos Mylan NV dijo el martes (20 de noviembre de 2018) que está retirando algunos lotes del medicamento para la presión arterial valsartan en […]
MIKE MCRAE https://www.sciencealert.com/limited-data-included-pre-clinical-investigator-brochures-german-review-boards 6 APR 2018 To make a call on whether the first phase of a clinical trial is to go ahead, a board of experts weighs up the risk and benefits based on sound research. At least, that’s the idea. Now a recently published study on the evidence that informs these decisions, says […]
El lobby farmacéutico en Brasil: un tema ausente en la agenda de investigación en salud pública (Pharmaceutical lobbying in Brazil: a missing topic in the public health research agenda) Francisco José Roma Paumgartten Rev Saude Publica. 2016; 50: 70. Published online 2016 Nov 24. doi:10.1590/S1518-8787.2016050006508 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152825/ Traducido por Salud y Fármacos En EE UU, […]
Safety Concerns Raised for 2 Novel Agents Pharmacy Practice News, 22 de enero de 2017 http://www.pharmacypracticenews.com/Clinical/Article/01-18/Safety-Concerns-Raised-for-2-Novel-Agents/46646/ses=ogst?enl=true The postmarketing safety record of two recently approved dru gs with novel mechanisms of action has raised concerns, leading investigators to examine how these agents got approved in the first place, according to a report by the Institute for […]
Seguir leyendo más sobre Safety Concerns Raised for 2 Novel Agents
La OMS sugiere vacunarse contra la fiebre amarilla para viajar a Brasil Nación y Salud, 19 d enero de 2018 http://www.nacionysalud.com/node/9956 En lo que va de 2018, las autoridades brasileñas confirmaron 20 muertes por fiebre amarilla. La Organización Mundial de la Salud (OMS) recomendó a quienes van a viajar a destinos turísticos de Brasil, incluido […]
Seguir leyendo más sobre La OMS sugiere vacunarse contra la fiebre amarilla para viajar a Brasil
http://www.cbc.ca/news/health/diclectin-pregnancy-nausea-vomiting-persaud-duchesnay-confidential-industry-documents-health-canada-1.4491300 Morning sickness drug Diclectin doesn’t work, confidential industry documents reviewed by doctor show Drug fell short of company’s own threshold for effectiveness, analysis reveals By Kelly Crowe, CBC News Posted: Jan 17, 2018 3:37 PM ET Last Updated: Jan 18, 2018 11:00 AM ET Confidential industry data reveals a morning sickness pill taken by hundreds of thousands of […]
FELIPE VILLAMOR The New York Times MANILA, Philippines — The Philippines suspended its school-based dengue immunization program on Friday after the French pharmaceutical giant Sanofi warned that its flagship vaccine, Dengvaxia, had been found to pose health risks in people not previously infected. The suspension came after health experts expressed worries about Sanofi’s announcement this week. […]
Seguir leyendo más sobre The Philippines has suspended dengue shots after a drug company’s warning
E-DRUG: Dutch Advisory committee recommends Government to take urgent steps to lower medicines prices ————————————————————————————————- [The extremely high prices for new medicines (cancer, hepatitis-c) has now reached a point in which the official Dutch Council for Public Health and Society has recommended the new Dutch Government to use 3 strategies to improve its negotiation position […]
Keeping Olmesartan on the Market Would Risk Patients’ Lives for Corporate Profits Nov. 15, 2017 Contact: Angela Bradbery, abradbery@citizen.org, (202) 588-7741 Don Owens, dowens@citizen.org, (202) 588-7767 WASHINGTON, D.C. – The U.S. Food and Drug Administration (FDA) should ban the sale of a certain hypertension medication because it can cause life-threatening health risks, Public Citizen said […]
Seguir leyendo más sobre FDA Should Ax Sale of Medication Linked to Severe Intestinal Disorder
Español
English